The Flow Cytometry Shared Resource (FACS-SR) provides AECC investigators with technologies required for fluorescence-based cell analysis and sorting. A broad range of research in a large proportion of AECC associated laboratories is supported by the FACS-SR, with connections to virtually all AECC programs and training activities. The instruments required for flow cytometry and cell sorting are intricate and expensive, making this a logical resource to provide through a centralized facility. In addition, cell sorting presents complex issues in biocontainment, requiring specialized laboratory space and highly trained personnel for proper management. The organization of these resources within the FACS-SR has proven to be an extremely efficient approach to creating a well supervised, quality controlled, cost effective and safe environment for FACS-based analysis and cell sorting. Since the last CCSG review in 2007, the FACS-SR has undergone major expansion to add new capabilities as well as a needed increase in the capacity for all services. Substantial additional laboratory space has been added, including rooms that are specially configured for enhanced BSL-2 work involved with sorting of primary human cells or potentially infectious material. Work performed to a great extent by AECC members has driven technology development in the FACS-SR, and supported multiple successful NIH Shared Instrumentation Grants over the past five years. This, along with substantial ongoing institutional support, has led to the acquisition of major new equipment and expansion of the resources and services provided by the FACS-SR. Three new cell sorters have been added to the facility since the last competing renewal, enabling accommodation of the growing need for this resource. Both Beckman-Coulter MoFlo and BD FACSAria sorters are operated by the facility, providing an extraordinarily advanced and versatile range of cell sorting applications. In addition, several analytical flow cytometers have been added to the facility's inventory, and facility staff has been increased to achieve maximum utilization of the instrumentation. The FACS-SR has also been highly successful at introducing novel technologies to AECC investigators in recent years, such as laser scanning cytometry and newly derived fluorescent proteins with unique spectral properties. The FACS-SR staff provides training on all the instruments, as well as consultation to assist with experimental design and instrument selection. A well established administrative structure ensures orderly management of facility operations and efficient delivery of services at the lowest possible cost.

Public Health Relevance

The Flow Cytometry facility provides a highly efficient, cost effective and safe environment for flow cytometry-based analysis and cell sorting experiments supporting the translational research mission and goals of the Albert Einstein Cancer Center (AECC). As an NCI-designated Cancer Center, AECC contributes to the national effort to reduce morbidity and mortality from cancer.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
5P30CA013330-41
Application #
8753336
Study Section
Subcommittee B - Comprehensiveness (NCI)
Project Start
Project End
Budget Start
2014-07-01
Budget End
2015-06-30
Support Year
41
Fiscal Year
2014
Total Cost
Indirect Cost
Name
Albert Einstein College of Medicine
Department
Type
DUNS #
City
Bronx
State
NY
Country
United States
Zip Code
10461
Van Arsdale, Anne R; Arend, Rebecca C; Cossio, Maria J et al. (2018) Insulin-like growth factor 2: a poor prognostic biomarker linked to racial disparity in women with uterine carcinosarcoma. Cancer Med 7:616-625
Ruiz, Penelope D; Gamble, Matthew J (2018) MacroH2A1 chromatin specification requires its docking domain and acetylation of H2B lysine 20. Nat Commun 9:5143
Rohan, Thomas; Ye, Kenny; Wang, Yihong et al. (2018) MicroRNA expression in benign breast tissue and risk of subsequent invasive breast cancer. PLoS One 13:e0191814
Walters, Ryan O; Arias, Esperanza; Diaz, Antonio et al. (2018) Sarcosine Is Uniquely Modulated by Aging and Dietary Restriction in Rodents and Humans. Cell Rep 25:663-676.e6
Racine, Jeremy J; Stewart, Isabel; Ratiu, Jeremy et al. (2018) Improved Murine MHC-Deficient HLA Transgenic NOD Mouse Models for Type 1 Diabetes Therapy Development. Diabetes 67:923-935
Frimer, Marina; Miller, Eirwen M; Shankar, Viswanathan et al. (2018) Adjuvant Pelvic Radiation ""Sandwiched"" Between Paclitaxel/Carboplatin Chemotherapy in Women With Completely Resected Uterine Serous Carcinoma: Long-term Follow-up of a Prospective Phase 2 Trial. Int J Gynecol Cancer 28:1781-1788
Kale, Abhijit; Ji, Zhejun; Kiparaki, Marianthi et al. (2018) Ribosomal Protein S12e Has a Distinct Function in Cell Competition. Dev Cell 44:42-55.e4
Lee, Chang-Hyun; Kiparaki, Marianthi; Blanco, Jorge et al. (2018) A Regulatory Response to Ribosomal Protein Mutations Controls Translation, Growth, and Cell Competition. Dev Cell 46:456-469.e4
Mao, Serena P H; Park, Minji; Cabrera, Ramon M et al. (2018) Loss of amphiregulin reduces myoepithelial cell coverage of mammary ducts and alters breast tumor growth. Breast Cancer Res 20:131
Mocholi, Enric; Dowling, Samuel D; Botbol, Yair et al. (2018) Autophagy Is a Tolerance-Avoidance Mechanism that Modulates TCR-Mediated Signaling and Cell Metabolism to Prevent Induction of T Cell Anergy. Cell Rep 24:1136-1150

Showing the most recent 10 out of 1508 publications